NIH-funded research NIH-funded research

Understanding drug resistance in Enterobacter cloacae complex bacteria

Official title: Assessing correlation between antimicrobial resistance genes and susceptibility phenotypes for Enterobacter cloacae complex isolates from the Vet-LIRN AMR monitoring program and clinical samples

Funded at Kansas State University · NIH-11073677 · Data updated 2026-11-12

This study looks at how certain bacteria that can cause serious infections, called Enterobacter cloacae complex, resist antibiotics, and it aims to help doctors find better ways to treat these infections, especially for patients who are more at risk.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionKansas State University
NIH-funded
Lab location1 site (Manhattan, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$50,000
NIH project number1U18FD008360-01
Project IDNIH-11073677 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who are immunocompromised or have experienced infections caused by Enterobacter cloacae complex.

Less likely to help

Patients with infections caused by other types of bacteria not related to Enterobacter cloacae complex may not benefit from this research.

What this research studies

This research investigates the relationship between antimicrobial resistance genes and how Enterobacter cloacae complex (ECC) bacteria respond to antibiotics. By analyzing clinical samples and those from food sources, the study aims to identify patterns of resistance that could inform treatment strategies. The research focuses on understanding how these bacteria, which can cause serious infections, develop resistance and how this impacts patient care, particularly for vulnerable populations. Patients may benefit from improved knowledge of how to treat infections caused by these bacteria.

Why it matters

Potential benefit: If successful, this research could lead to better treatment options for infections caused by multi-drug resistant bacteria.

How similar studies have gone: Previous research has shown success in understanding antimicrobial resistance in similar bacterial species, indicating that this approach has potential for meaningful insights.

Where this research is happening

  • Kansas State University
    Manhattan, United States
    Active

Researchers

  • Principal investigator: Bai, Jianfa — Kansas State University
  • Study coordinator: Bai, Jianfa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.